2019-07-18T13:18:12-05:00 2018-12-31 EISNERAMPER LLP 750 THIRD AVENUE NEW YORK NY 100172703 990 2018-01-01 364825921 The Mark Foundation for Cancer Research (US) LTD % S PATRICK LEWIS MARK 6468665950 10 EAST 53RD STREET 13TH FLOOR NEW YORK NY 10022 MICHELE CLEARY PHD CEO 6468665950 2019-07-18 true CANDICE METH P01306891 2129498700 64.238.150.4 26505220192035000000 2019-07-18 P D611A41C46BF25E5A65C9B6AAB3989918C636A13 D611A41C46BF25E5A65C9B6AAB3989918C636A13 2018 2019-02-21 02:37:17Z MICHELE CLEARY PHD 10 EAST 53RD STREET 13TH FLOOR NEW YORK NY 10022 40519118 false X WWW.THEMARKFOUNDATION.ORG X 2015 DE THE MARK FOUNDATION FOR CANCER RESEARCH IS COMMITTED TO ADVANCING BASIC BREAKTHROUGH CANCER RESEARCH, DETECTION, PREVENTION AND CURES FOR CANCER PATIENTS. 4 3 10 0 0 11508 10536000 40142140 0 0 14135 376978 0 0 10550135 40519118 3652006 35601108 0 0 1010561 1973152 0 0 48850 770321 965761 5432888 38540021 5117247 1979097 8121943 33818430 2795597 23857292 5326346 9961138 X THE MISSION OF THE MARK FOUNDATION FOR CANCER RESEARCH (U.S.) LTD. IS TO PROMOTE, ENCOURAGE, AND SUPPORT CHARITIES AND CHARITABLE ENDEAVORS ESTABLISHED FOR THE ADVANCEMENT, PROMOTION AND BENEFIT OF RESEARCH INTO THE CAUSES OF CANCERS IN THE HUMAN BODY, THE DISCOVERY OF CURES FOR SUCH CANCERS, AND THE ALLEVIATION OF THE PAIN AND SUFFERING CAUSED BY SUCH CANCERS. THE FOUNDATION'S GOAL IS TO REWARD CUTTING-EDGE, INNOVATIVE IDEAS THAT TRANSFORM PATIENT CARE AND ANSWER THE MOST COMPLEX QUESTIONS ABOUT CANCER BIOLOGY. false false 37357976 35601108 THE FOUNDATION'S grantS reward innovative thinking that advances the understanding of cancer biology and improves oncology treatment paradigms. THE FOUNDATION supports individual investigators, as well as multidisciplinary collaborative teams conducting research across cancer types. THE grantees become part of THE FOUNDATION'S network of the best scientific minds in cancer research and technological innovation. Grant submissions undergo rigorous peer review by the foundations scientific advisory committee or recommended subject matter experts and are held to the strictest standards of scientific excellence. 37357976 true true false false false false false false false false true true false false true true true false false false false true false false false false false true false true false false false false false false false false false false false false false false false false false true X 65 0 true 10 true true true false false false false false false false false false false false X 4 3 true false false false false false false true false false false true true true true true true true true false NY X S PATRICK LEWIS 6468665950 10 EAST 53RD STREET 13TH FLOOR NEW YORK NY 10022 X STEVEN GAUCI DIRECTOR (THROUGH 05/31/2018) 2.0 0.0 X 0 0 0 ROSS LEVINE MD PHD DIRECTOR (AS OF 06/1/2018) 2.0 0.0 X 10000 0 0 KEVIN O'FLAHERTY DIRECTOR (AS OF 06/1/2018) 2.0 0.0 X 0 0 0 WILLIAM ALLEN SHAPARD DIRECTOR (AS OF 06/1/2018) 2.0 0.0 X 0 0 0 STUART THOMSON DIRECTOR 2.0 0.0 X 0 0 0 MICHELE CLEARY PHD CHAIRMAN OF THE BOARD / CEO 40.0 0.0 X 426880 0 172935 S PATRICK LEWIS HEAD OF FINANCE AND OPERATIONS 40.0 0.0 X 244122 0 46747 RYAN SCHOENFELD PHD SENIOR SCIENTIFIC DIRECTOR 40.0 0.0 X 227290 0 71677 REBECCA BISH PHD SCIENTIFIC DIRECTOR 40.0 0.0 X 186465 0 83391 CHRISTA JUSTUS CHIEF COMMUNICATIONS OFFICER 40.0 0.0 X 196875 0 42022 1291632 0 416772 5 false true false ARNOLD PORTER KAYE SCHOLER LLP 601 MASSACHUSETTS AVE NW WASHINGTON DC 200013743 LEGAL SERVICES 240387 1 40142140 40142140 0 376978 376978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 40519118 376978 11085052 11085052 0 24516056 24516056 0 1204042 758952 409565 35525 0 493117 262858 230259 157868 55731 98833 3304 19404 5000 14404 98721 56860 40046 1815 0 218429 151280 67060 89 64145 64145 0 0 0 17775 2155 15620 0 23219 3472 19747 37485 29234 8251 0 329732 190343 132500 6889 73526 69871 3655 0 40148 40148 0 0 43029 25915 16215 899 4018 4018 PAYROLL PROCESSING FEES 16453 9872 6252 329 HONORARIUM 93950 93950 OTHER EXPENSES 3852 1227 2625 38540021 37357976 1133195 48850 922265 772594 4037511 25260696 0 0 0 0 0 0 0 0 0 0 0 0 35756 131911 144776 59513 114255 85263 0 0 3000001 7555696 0 0 0 0 12155 12270 8121943 33818430 351411 420783 2424506 23424972 0 0 0 0 0 0 0 0 0 0 0 0 19680 11537 2795597 23857292 X 5326346 9961138 0 0 0 0 5326346 9961138 8121943 33818430 X 1979097 2555695 100000 X false true X true false X 0 0 500000 10536000 40142140 51178140 0 0 0 0 500000 10536000 40142140 51178140 0 51178140 20684 376978 397662 0 0 51575802 X 46171 24368 21803 98605 35145 63460 85263 PRIVATE COMPANIES - 7555696 F 7555696 0 DEFERRED RENT 11537 11537 X 43089813 2555695 15000 2570695 40519118 40519118 38555021 15000 15000 38540021 38540021 FORM 990, SCHEDULE D, PART X, LINE 2 The Foundation is subject to the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") Topic 740, Income Taxes, relating to the accounting and reporting for uncertainty in income taxes. For the Foundation, these provisions could BE APPLICABLE TO THE INCURRENCE OF UNRELATED BUSINESS INCOME TAX ("UBIT") ON the DISALLOWED TRANSIT AND QUALIFIED PARKING FRINGe BENEFITS. Because the Foundation has accrued the tax liability for UBIT and because of the Foundations tax-exempt status, management believes ASC Topic 740 has not had, and is not expected to have, a material impact on the Foundation's financial statements. true Europe (Including Iceland and Greenland) 0 0 Grantmaking 24530407 0 0 0 0 24530407 24530407 Europe (Including Iceland and Greenland) Research 12867072 WIRE FMV Europe (Including Iceland and Greenland) Research 11487605 WIRE FMV Europe (Including Iceland and Greenland) Research 175730 WIRE FMV 2 1 false false false false false false FORM 990, SCHEDULE F, PART I, LINE 2 THE FOUNDATION AWARDS RESERACH GRANTS BASED UPON THE GUIDANCE AND INPUT OF THE SCIENTIFIC ADVISORY COMMITTEE AND OTHER HIGHLY REGARDED SCIENTISTS SPECIALIZING IN CANCER RESEARCH. THE FOUNDATION CLOSELY MONITORS THE PROGRESS OF EACH GRANT AWARDED. THERE IS FREQUENT COMMUNICATION BETWEEN GRANTEES AND FOUNDATION STAFF REGARDING THE PROGRESS OF EACH GRANT. IN THE CASE OF MULTI-YEAR GRANTS, PROGRESS IS VERIFIED BEFORE ADDITIONAL GRANTS ARE AWARDED. FORM 990, SCHEDULE F, PART I, LINE 3, COLUMN (F) AMOUNT REPORTED USING THE ACCRUAL METHOD OF ACCOUNTING. true American Association for Cancer Research 615 Chestnut Street Philadelphia PA 19106 236251648 501(C)(3) 466388 Research Chordoma Foundation PO Box 2127 Durham NC 27702 248423943 501(C)(3) 300000 Research Columbia University 116th St New York NY 10027 135598093 501(C)(3) 735649 Research Damon Runyon-Walter Winchell Foundation 55 Broadway Suite 302 New York NY 10006 131933825 501(C)(3) 395793 Research Dana Farber Cancer Institute Inc 450 Brookline Avenue Boston MA 02215 042263040 501(C)(3) 1546298 Research Emory University 1599 Clifton Rd 4th Floor Atlanta GA 30322 580566256 501(C)(3) 121000 Research Fred Hutchinson Cancer Research Center 1100 Fairview Ave Seattle WA 98109 237156071 501(C)(3) 735649 Research Ichan School of Medicine at Mount Sinai One Gustave L Levy Place NY NY 10029 136171197 501(C)(3) 735649 Research John Hopkins University 733 N Broadway Baltimore MD 21205 520595110 501(C)(3) 325000 Research Life Sciences Research Foundation 3520 San Martin Dr Baltimore MD 21218 521231801 501(C)(3) 191269 Research Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY 100656007 131924236 501(C)(3) 100000 Research New York Genome Center Inc 101 AVE OF THE AMERICAS New York NY 10013 800631734 501(C)(3) 1000000 Research New York University NYULMC One Park Avenue 11th Floor New York NY 10016 135562308 501(C)(3) 385000 Research Oregon Health and Science University 2525 SW 3rd Avenue Suite 245 Portland OR 97201 931176109 501(C)(3) 405203 Research The Ohio State University 1960 Kenny Road Columbus OH 432101016 136025986 501(C)(3) 187772 Research The Regents of the University of California - San 9500 Gilman Drive La Jolla CA 920930953 956006144 501(C)(3) 735649 Research The Regents of the University of California Berek 2195 Hearst Avenue Room 159 Berkeley CA 947201101 946002123 501(C)(3) 350000 Research The Regents of the University of California Los A 1125 Murphy Hall Los Angeles CA 900957089 956006143 501(C)(3) 735649 Research The Regents of The Univ of California SF 1855 Folsom St San Francisco CA 94143 946036493 501(C)(3) 75000 Research Research Inst Nationwide Children's Hosp 700 Childrens Drive Columbus OH 43205 316056230 501(C)(3) 75000 Research University of Maryland School of Medicine 220 Arch Street Rm 02-148 Baltimore MD 21201 526002033 501(C)(3) 75000 Research University of Pennsylvania 3451 Walnut St 5th Floor Franklin Building Philadelphia PA 191046205 231352685 501(C)(3) 810649 Research University of Utah 201 Presidents CIR Salt Lake City UT 84112 876000525 501(C)(3) 109238 Research Weill Medical College of Cornell University 1300 York Avenue New York NY 10065 131623978 501(C)(3) 379000 Research 24 0 FORM 990, SCHEDULE I, PART I, LINE 2 THE FOUNDATION REQUIRES GRANT RECIPIENTS TO COMPLY WITH STATED TERMS AND CONDITIONS GOVERNING EACH RESEARCH PROGRAM AWARDED, INCLUDING THE SUBMISSION OF PROGRESS REPORTS. DISBURSEMENT OF FUNDS IS CONTINGENT UPON ACCEPTANCE OF THESE TERMS AND TIMELY SUBMISSION OF REPORTS. X X X false false false false false false false true false MICHELE CLEARY PHD CHAIRMAN OF THE BOARD / CEO 326880 0 100000 0 0 0 170550 0 2385 0 599815 0 100000 0 S PATRICK LEWIS HEAD OF FINANCE AND OPERATIONS 186610 0 34000 0 23512 0 44373 0 2374 0 290869 0 34000 0 RYAN SCHOENFELD PHD SENIOR SCIENTIFIC DIRECTOR 201786 0 0 0 25504 0 69840 0 1837 0 298967 0 0 0 REBECCA BISH PHD SCIENTIFIC DIRECTOR 183965 0 2500 0 0 0 43529 0 39862 0 269856 0 0 0 CHRISTA JUSTUS CHIEF COMMUNICATIONS OFFICER 179375 0 17500 0 0 0 39637 0 2385 0 238897 0 0 0 FORM 990, SCHEDULE J, PART I, LINE 7 STAFF BONUSES ARE AWARDED ON A DISCRETIONARY BASIS UPON THE RECOMMENDATION OF THE CHIEF EXCECUTIVE OFFICER AND APPROVAL BY THE BOARD OF DIRECTORS. FORM 990, SCHEDULE J, PART I, LINE 7 AND PART II, COLUMN B(II) THE CHIEF EXECUTIVE OFFICER IS ENTITLED TO A CONTRACTUAL DISCRETIONARY BONUS, WHICH IS CONSIDERED A NON-FIXED PAYMENT, AS WELL AS A LONG-TERM INCENTIVE PAYMENT WHICH WAS A FIXED PAYMENT CONTINGENT UPON HER CONTINUED EMPLOYEMENT. BOTH THE CONTRACTUAL BONUS AND LONG-TERM INCENTIVE PAYMENT ARE OUTLINED IN HER EMPLOYMENT AGREEMENT AND WERE SUBJECT TO THE APPROVAL, PRIOR TO PAYMENT, BY THE BOARD OF DIRECTORS. FORM 990, PART I LINES 7A AND 7B; PART V, LINES 3A AND 3B DUE TO THE TAX CUTS AND JOBS ACT, THE FOUNDATION IS SUBJECT TO UNRELATED BUSINESS INCOME TAX ON THE DISALLOWED TRANSIT AND QUALIFIED PARKING FRINGE BENEFITS AND, ACCORDINGLY, FILED THE FEDERAL FORM 990-T. FORM 990, PART VI, SECTION A, LINE 2 TWO MEMBERS OF THE BOARD OF DIRECTORS ARE EMPLOYEES OF PAMPLONA CAPITAL MANAGEMENT LLC. ALEX KNASTER (FOUNDER OF THE MARK FOUNDATION FOR CANCER RESEARCH (U.S.) LTD.) IS THE FOUNDER AND CEO OF PAMPLONA CAPITAL MANAGEMENT LLC. MR. KNASTER DOES NOT HOLD A BOARD SEAT ON THE FOUNDATION'S BOARD. FORM 990, PART VI, SECTION A, LINE 8B GIVEN THE CURRENT SIZE OF THE FOUNDATION'S BOARD OF DIRECTORS, THE FOUNDATION HAS YET TO CREATE COMMITTEES. ALL GOVERNING RELATED BUSINESS OF THE FOUNDATION IS CONDUCTED BY THE EXISTING DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FOUNDATION'S 990 IS PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW AND COMMENT PRIOR TO ITS ELECTRONIC FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ALL MEMBERS OF THE BOARD OF DIRECTORS AND KEY MEMBERS OF MANAGEMENT ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY AND SIGN IT ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION B, LINES 15A AND 15B THE CHIEF EXECUTIVE OFFICER'S COMPENSATION IS REVIEWED ON AN ANNUAL BASIS BY THE BOARD OF DIRECTORS USING COMPARABLE MARKET DATA. COMPENSATION OF KEY EMPLOYEES IS DETERMINED BY THE CHIEF EXECUTIVE OFFICER AND APPROVED BY THE BOARD OF DIRECTORS ON AN ANNUAL BASIS, AS PART OF THE FOUNDATION'S BUDGET PROCESS. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S FORM 990 IS AVAILABLE UPON REQUEST. GOVERNING DOCUMENTS ARE ONLY DISTRIBUTED INTERNALLY TO THE BOARD OF DIRECTORS AND MANAGEMENT. FORM 990, PART VII, SECTION A, LINE 2 ROSS LEVINE MD, PH.D RECEIVED AN HONORARIUM FROM THE FOUNDATION FOR HIS CONTRIBUTIONS TO THE FOUNDATION AS THE CHAIR OF THE FOUNDATION'S SCIENTIFIC ADVISORY COMMITTEE; NOT IN HIS CAPACITY AS A MEMBER OF THE BOARD OF DIRECTORS. FORM 990, PART XI, LINE 9 ADJUSTMENT TO OPENING NET ASSETS TO APPROPRIATELY REFLECT PRIOR YEAR BALANCE.